These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11756168

  • 1. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.
    Lisman T, Mosnier LO, Lambert T, Mauser-Bunschoten EP, Meijers JC, Nieuwenhuis HK, de Groot PG.
    Blood; 2002 Jan 01; 99(1):175-9. PubMed ID: 11756168
    [Abstract] [Full Text] [Related]

  • 2. Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
    Antovic JP, Antovic A, He S, Tengborn L, Blombäck M.
    Haemophilia; 2002 Nov 01; 8(6):781-6. PubMed ID: 12410647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A.
    Lisman T, de Groot PG, Lambert T, Røjkjaer R, Persson E.
    J Thromb Haemost; 2003 Oct 01; 1(10):2175-8. PubMed ID: 14521601
    [Abstract] [Full Text] [Related]

  • 5. Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
    Antovic JP, Antovic A.
    Thromb Haemost; 2003 Oct 01; 90(4):620-7. PubMed ID: 14515182
    [Abstract] [Full Text] [Related]

  • 6. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D, Szlam F, Molinaro RJ, Escobar MA, Levy JH, Tanaka KA.
    Haemophilia; 2010 May 01; 16(3):510-7. PubMed ID: 20050927
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D, Görlinger K, Gisbertz C, Dusse F, Peters J.
    Anesth Analg; 2012 Jun 01; 114(6):1182-8. PubMed ID: 22104068
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct 01; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 13. Concizumab improves clot formation in hemophilia A under flow.
    Jewell MP, Ashour Z, Baird CH, Manco Johnson M, Warren BB, Wufsus AR, Pallini C, Dockal M, Kjalke M, Neeves KB.
    J Thromb Haemost; 2024 Sep 01; 22(9):2438-2448. PubMed ID: 38815755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia.
    Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS.
    Arterioscler Thromb Vasc Biol; 2007 Mar 01; 27(3):683-9. PubMed ID: 17204663
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
    Keshava S, Sundaram J, Rajulapati A, Pendurthi UR, Rao LV.
    J Thromb Haemost; 2016 Mar 01; 14(3):546-50. PubMed ID: 26727350
    [Abstract] [Full Text] [Related]

  • 20. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
    Sørensen B, Ingerslev J.
    J Thromb Haemost; 2004 Jan 01; 2(1):102-10. PubMed ID: 14717973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.